POWERFUL:Zero pain, sustained1,3
Pain freedom at 2 hours (co-primary endpoint) was demonstrated in 21% (UBRELVY® 50 mg) vs 13% (placebo).1,3 Sustained pain freedom from 2 to 24 hours (secondary endpoint) was achieved in 14% (UBRELVY 50 mg) vs 8% (placebo)1,3,4
RAPID:Quick pain relief1
Pain relief at 2 hours was demonstrated in 62% (UBRELVY 50 mg) vs 49% (placebo) when taken immediately or within 4 hours of onset1,3,5
PRE-HEADACHE:Clinical evidence3
Absence of headache pain of moderate to severe intensity within 24 hours after dosing in the pre-headache phase (primary endpoint)3
INDICATION
UBRELVY® (ubrogepant) is indicated for the acute treatment of migraine with or without aura in adults. UBRELVY is not indicated for the preventive treatment of migraine.
Get patients started
Once you've decided to prescribe UBRELVY, enable access for your patients with our UBRELVY Contact Center and learn how eligible commercially insured patients may pay as little as $0.†
Help enable access16-count pack is available for your UBRELVY patients
Migraine attacks can be unpredictable.6 Prepare your patients with a 16-count package of UBRELVY 100 mg tablets.
View dosingMany patients experience
pre-headache symptoms7
See the results of administering UBRELVY during the pre-headache phase of a migraine attack.
Explore pre-headache data*In clinical studies, patients took UBRELVY within 4 hours of a migraine attack.5
†Eligibility: Available to patients with commercial insurance coverage for UBRELVY® (ubrogepant) who meet eligibility criteria. This co-pay assistance program is not available to patients receiving prescription reimbursement under any federal, state, or government-funded insurance programs (for example, Medicare [including Part D], Medicare Advantage, Medigap, Medicaid, TRICARE, Department of Defense, or Veterans Affairs programs) or where prohibited by law. Offer subject to change or termination without notice. Restrictions, including monthly maximums, may apply. This is not health insurance. For full Terms and Conditions, visit https://www.ubrelvy.com/savings-terms or call 1-844-577-6239, for additional information. To learn about AbbVie’s privacy practices and your privacy choices, visit https://abbv.ie/corpprivacy.